These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 99528)

  • 1. Total haemolytic complement activity in apparently healthy Pakistanis and patients with liver disease.
    Siddiqui M; Zuberi SJ
    J Pak Med Assoc; 1978 Jun; 28(6):67-8. PubMed ID: 99528
    [No Abstract]   [Full Text] [Related]  

  • 2. DNCB sensitivity in healthy Pakistani subjects and patients with liver disease.
    Zuberi SJ; Siddiqui M; Ahmed SA; Kara RY
    Pahlavi Med J; 1978 Jan; 9(1):14-20. PubMed ID: 652381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of abnormalities in host defences against bacterial infection in liver disease.
    Rajkovic IA; Williams R
    Clin Sci (Lond); 1985 Mar; 68(3):247-53. PubMed ID: 2982530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigen e and anti-e in primary liver cancer, cirrhosis, and viral hepatitis in Senegal].
    Sankale M; Sow AM; Thermos M
    Afr J Med Med Sci; 1977 Sep; 6(3):157-8. PubMed ID: 97943
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R; Farini R; Chiaramonte M
    Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosette forming T lymphocytes in healthy subjects and patients with liver disease.
    Lodi TZ; Zuberi SJ
    J Pak Med Assoc; 1977 Oct; 27(10):408-10. PubMed ID: 416238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors causing decrease in complement activity in chronic liver diseases].
    Tsuji T; Sato M; Nozaki H; Mizuno Y; Kosaka K
    Igaku To Seibutsugaku; 1970 Oct; 81(4):155-61. PubMed ID: 5531565
    [No Abstract]   [Full Text] [Related]  

  • 8. [HBS antigen and liver diseases].
    Blüger A; Kartaschowa O; Zalcmane V; Saldava L
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):56-64. PubMed ID: 6307637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-1-Foeto protein (AFP) and hepatitis B surface antigen (HBsAg) in various hepatic disorders.
    Gupta SC; Satsangi JK; Mehrotra TN; Sinha SN
    J Assoc Physicians India; 1979 Jan; 27(1):1-6. PubMed ID: 92470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum complement and hepatic diseases].
    Kourilsky O; Leroy C; Peltier AP
    Nouv Presse Med; 1973 Jun; 2(25):1720. PubMed ID: 4718548
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonparticipation of C1q in the decrease of complement activity in the cold in sera of patients with chronic liver diseases.
    Yoshida H; Morito T; Onizawa N; Kasukawa R
    Int Arch Allergy Appl Immunol; 1980; 62(4):433-41. PubMed ID: 6247290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response in patients with liver disease.
    Steigmann F; Dourdourekas D; Shobassay N; Vittal SB; Szanto PB; Ainis H; Khin U; Telischi M
    Am J Gastroenterol; 1974 May; 61(5):349-55. PubMed ID: 4134965
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 14. [The complement system in hepatopathies].
    De la Tour B; Kazatchkine M
    Ann Med Interne (Paris); 1985; 136(3):222-4. PubMed ID: 3161444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total haemolytic complement after liver transplantation and in liver disease.
    Pagaltsos AP; Smith MG; Eddleston AL; Williams R
    Transplantation; 1972 Jul; 14(1):41-6. PubMed ID: 4338531
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemolytic complement, anticomplementry activity and hepatitis B antigen in sera of patients with cirrhosis of the liver.
    Kelkar SS; Karhade NV; Kotwal SE
    Indian J Med Res; 1975 Jan; 63(1):41-4. PubMed ID: 1213709
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum complement in chronic liver disease.
    Potter BJ; Trueman AM; Jones EA
    Gut; 1973 Jun; 14(6):451-6. PubMed ID: 4737028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of complement activity in chronic liver disease].
    Di Simone A; Coraggio F; Riegler G; Ciotola R
    Minerva Dietol Gastroenterol; 1977; 23(3):137-44. PubMed ID: 618090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum complement levels of the patients with various diseases].
    Inai S
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):154-67. PubMed ID: 5274224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.